Serial Number | 79392554 |
Word Mark | GAIPET |
Filing Date | Wednesday, November 8, 2023 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, December 10, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, December 10, 2024 |
Goods and Services | Medicines for human purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; biochemical medicines for the treatment of tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; pharmaceutical preparations for the treatment of tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; chemical reagents for medical and veterinary purposes; biological preparations for medical purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; reagent paper for medical purposes; drugs for medical purposes for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia; diagnostic preparations for medical purposes; vaccines |
Pseudo Mark | GAI PET |
Goods and Services | Chemical reagents, other than for medical or veterinary purposes; biological preparations for use in industry and science, other than for medical or veterinary purposes; diagnostic preparations for scientific use, other than for medical or veterinary purposes; test paper, chemical; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemicals preparations for scientific use; chemical substances for analyses in laboratories for scientific use, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purpose; biological preparations for cell culture, other than for medical or veterinary use; diagnostic reagents and preparations for scientific use except for medical and veterinary use; active chemical ingredients for use in the manufacture of pharmaceuticals for treating tumors, asthma, arthritis, viral diseases, respiratory diseases, inflammation, fibrosis, hypertension, hyperlipidemia, cardiovascular diseases, eye diseases, angina, diabetes, and insomnia |
Goods and Services | Scientific development and research services in the field of drugs; vaccine research and development services; scientific research and development of new products for others; scientific research; research of biochemistry; biotechnology research; pharmaceutical drug research; development services in the field of pharmaceutical drugs; medical research service; biomedical research services |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 1, 2024 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 1, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, April 1, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | ARGORNA PHARMACEUTICALS CO., LTD |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | CN |
Party Name | ARGORNA PHARMACEUTICALS CO., LTD |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | CN |
Event Date | Event Description |
Monday, April 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, April 5, 2024 | APPLICATION FILING RECEIPT MAILED |
Monday, June 17, 2024 | ASSIGNED TO EXAMINER |
Thursday, March 28, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Friday, June 28, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Wednesday, July 24, 2024 | REFUSAL PROCESSED BY MPU |
Sunday, November 17, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Sunday, November 17, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Sunday, November 17, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, November 18, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, December 4, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, December 10, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, December 10, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Sunday, August 11, 2024 | REFUSAL PROCESSED BY IB |
Thursday, June 27, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, July 24, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |